Autori: Andric Zoran G
| Naslov | Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies (Article) |
| Autori | Weiss Jared Goldschmidt Jerome Andric Zoran G Dragnev Konstantin H Gwaltney Chad Skaltsa Konstantina Pritchett Yili Antal Joyce M Morris Shannon R Daniel Davey |
| Info | CLINICAL LUNG CANCER, (2021), vol. 22 br. 5, str. 449-460 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC (Article) |
| Autori | Jassem Jacek ... Andric Zoran G ... (broj koautora 19) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 11, str. 1872-1882 |
| Projekat | Roche HoldingGenentech; F. Hoffmann-La Roche Ltd.Hoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Polycystic Ovary Syndrome: A Contemporary Clinical Approach (Review) |
| Autori | Bjekic-Macut Jelica D Vukasin Tamara Velija-Asimi Zelija Burekovic Azra Zdravkovic Marija D Andric Zoran G Brankovic Marija S Crevar-Marinovic Slobodanka Madic Tatjana Stanojlovic Olivera P Milutinovic Danijela V Livadas Sarantis Mastorakos George |
| Info | CURRENT PHARMACEUTICAL DESIGN, (2021), vol. 27 br. 36, str. 3812-3820 |
| Projekat | Ministry of Education, Science and Technological Development, Serbia [451-03-68/2020-14/200007] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2). (Meeting Abstract) |
| Autori | Goel Shom O'Shaughnessy Joyce Tan Antoinette R Milev-Krastev Boris Rugo Hope S Aftimos Philippe Georges Yardley Denise A Andric Zoran G Wolfgang Curt Douglas Sorrentino Jessica Tao Wenli Beelen Andrew Paul Malik Rajesh K Jain Sarika |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. - |
| Projekat | G1 Therapeutics, Inc |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | HERIZON: A phase 1B/2 open-label study of imu-131 HER2/neu peptide vaccine PLUS standard of care chemotherapy with randomization in phase 2 in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction. (Meeting Abstract) |
| Autori | Laeufle Rita ... Andric Zoran G ... Nikolic Ivan V ... Radosavljevic Davorin Z ... (broj koautora 16) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. - |
| Projekat | Imugene Australia |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis. (Meeting Abstract) |
| Autori | Trukhin Dmytro Poddubskaya Elena Andric Zoran G Bondarenko Igor N Shevnia Serhii Zaric Bojan Bellala Ravishankar Charoentum Chaiyut Perez Luis Bullo Felicitas Garcia Fernanda |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. - |
| Projekat | mAbxience Research |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression (Meeting Abstract) |
| Autori | Andric Zoran G Ceric Timur Rancic Milan H Jakopovic Marko Aix S Ponce Ramlau Rodryg Ulanska M Caldwell C Ferrari D Annis A Vukovic V Zaric Bojan |
| Info | ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 5, str. S1166-S1166 |
| Projekat | Aileron Therapeutics Inc. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB plus ) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C (Meeting Abstract) |
| Autori | Dziadziuszko R ... Andric Zoran G ... (broj koautora 20) |
| Info | ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 5, str. S950-S951 |
| Projekat | F. Hoffmann-La Roche, Ltd.Hoffmann-La Roche |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | A phase I/II dose-escalation and expansion study of ZN-c5, an oral selective estrogen receptor degrader (SERD), as monotherapy and in combination with palbociclib in patients with advanced estrogen receptor (ER)+/HER2-breast cancer (Meeting Abstract) |
| Autori | Abramson V ... Andric Zoran G Milovic-Kovacevic Marijana M Trifunovic Jasna D ... (broj koautora 16) |
| Info | ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 5, str. S619-S619 |
| Projekat | Zentalis Pharmaceuticals |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | A Phase 1b/2 Open-Label Study with Randomization in Phase 2 of Imu-131 Her2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients with Her2/Neu Overexpressing Metastatic Or Advanced Adenocarcinoma of the Stomach Or Gastroesophageal Junction. (Meeting Abstract) |
| Autori | Maglakelidze Marina ... Andric Zoran G Nikolic Ivan V ... Radosavljevic Davorin Z Petrovic Zoran ... (broj koautora 17) |
| Info | CANCER RESEARCH, (2021), vol. 81 br. 13, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
